The objective of this project is to develop techniques for using monoclonal antibodies labeled with 212bismuth, an alpha particle-emitting radionuclide, as in vitro ot in vivocytotoxic agents. antibody conjugates will be developed forradioimaging to localize to the tumor site only, with minimal…
More